Indoco Remedies informs about press release

22 Mar 2022 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed that it enclosed a press today titled ‘Indoco Remedies receives USFDA approval for Lacosamide Tablets’.

The above information is a part of company’s filings submitted to BSE.


Indoco Remedies Share Price

184.95 2.25 (1.23%)
24-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.80
Dr. Reddys Lab 1259.60
Cipla 1219.30
Zydus Lifesciences 886.50
Lupin 2331.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×